RecruitingNot ApplicableNCT06341270

Efficacy of TEAS on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy

Efficacy of Transcutaneous Electrical Acupoint Stimulation on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy:a Prospective, Randomized Controlled Trial


Sponsor

West China Hospital

Enrollment

524 participants

Start Date

May 6, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to access the effect of transcutaneous electrical acupoint stimulation on postoperative pain in patients undergoing hepatectomy


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Inclusion Criteria1

  • Age 18-80 years old; ASA physical status classⅠ-Ⅲ; Patients scheduled for elective hepatectomy.

Exclusion Criteria1

  • Have a history of epilepsy; Rash or local infection over the acupoint stimulation skin area; Pregnancy or breastfeeding; Mental retardation, psychiatric, or neurological disease; Inability to comprehend the numeric rating scale (NRS); Implantation of a cardiac pacemaker, cardioverter, or defibrillator; Chronic opioid use; Metastases in other organs;

Interventions

DEVICEtranscutaneous electrical acupoint stimulation

transcutaneous electrical acupoint stimulation Transcutaneous electrical acupoint stimulation (TEAS) is a contemporary modification of traditional acupuncture that sends electrical impulses into acupoints through electrodes on the skin surface. In the TEAS group, patients will receive TEAS 30min before anesthesia until be discharged from the postanaesthesia care unit (PACU). The same treatment will be performed on the 1st, 2nd and 3rd days after surgery.The stimulation intensity will be adjusted in accordance with the maximal level tolerated by each patient.

DEVICEsham transcutaneous electrical acupoint stimulation

Patients in the sham group will receive electrode attachment but without stimulation.


Locations(1)

West China Hospital

Chengdu, Sichuan, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06341270


Related Trials